Treatment interruption in HIV infected patients: Clinical and biological evolution;Interruption thérapeutique chez des patients infectés par le virus de l'immunodéficience humaine: Évolution clinique et biologique

Medecine et Maladies Infectieuses

Volumn 35, Issue 11, 2005, Pages 525-529

  Giard, M ^a   Boibieux, A ^a   Ponceau, B ^a   Biron, F ^a   Braun, E ^a   Issartel, B ^a   Lalain, C ^a   Lippmann, J ^a   Daoud, F ^a   Delbrassine, C ^a   Delorme, C ^a   Chidiac, C ^a   Peyramond, D ^a  

^a CROIX ROUSSE HOSPITAL   (France)

Author keywords

HAART; HIV1; Treatment interruption

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVALUATION; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; RETROSPECTIVE STUDY; VIREMIA; VIRUS LOAD;

ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT REFUSAL;

EID: 29244460384     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2005.05.007     Document Type: Article

References (27)

1. A. Fauci Research sheds light on treatment interruption Aids Alert 16 2001 114 116
2. M. Dybul, M. Daucher, M.A. Jensen, C.W. Hallahan, T.W. Chun, and M. Belson Genetic characterization of rebounding human immunodeficiency virus type 1 in plasma during multiple interruptions of highly active antiretroviral therapy J. Virol. 77 2003 3229 3237
3. J. Lisziewicz, and F. Lori Structured treatment interruptions in HIV/AIDS therapy Microbes Infect. 4 2002 207 214
4. B. Hirschel Planned interruptions of anti-HIV treatment Lancet Infect. Dis. 1 2001 53 59
5. R.M. Gulick Structured treatment interruption in patients infected with HIV: a new approach to therapy Drugs 62 2002 245 253
6. F. Lori, and J. Lisziewicz Structured treatment interruptions for the management of HIV infection JAMA 286 2001 2981 2987
7. M. Dybul Structured Treatment Interruption: Approaches and Risks Curr. Infect. Dis. Rep. 4 2002 175 180
8. J. Martinez-Picado, E. Negredo, L. Ruiz, A. Shintani, C.R. Fumaz, and C. Zala Alternation of antiretroviral drug regimens for HIV infection Ann. Intern. Med. 139 2003 81 89
9. V. Miller Structured treatment interruptions in antiretroviral management of HIV-1 Curr. Opin. Infect. Dis. 14 2001 29 37
10. R.B. Moss, C. Brandt, W.K. Giermakowska, J.R. Savary, G. Theofan, and M. Zanetti HIV-specific immunity during structured antiviral drug treatment interruption Vaccine 21 2003 1066 1071
11. F. Lori, A. Foli, R. Maserati, E. Seminari, J. Xu, and L. Whitman Control of HIV during a structured treatment interruption in chronically infected individuals with vigorous T cell responses HIV Clin. Trials 3 2002 115 124
12. C.A. Benson Structured treatment interruption in HIV infection AIDS Read. 11 2001 99 102
13. P. Taffe, M. Rickenbach, B. Hirschel, M. Opravil, H. Furrer, and P. Janin Impact of occasional short interruptions of HAART on the progression of HIV infection: results from a cohort study AIDS 16 2002 747 755
14. D. Rey, M.P. Schmitt, G. Hess-Kempf, V. Krantz, M. Partisani, and C. Bernard-Henry Structured therapeutic interruption in patients infected with HIV-1 experiencing a block in their antiretroviral treatment: preliminary results Pathol. Biol. 49 2001 559 566
15. J. Lawrence, D. Mayers, and K. Huppler Hullsiek Structured treatment interruption in patients with multidrug-resistant human immunodeficiency virus N. Engl. J. Med. 349 2003 837 846
16. C. Katlama, S. Dominguez, K. Gourlain, C. Duvivier, C. Delaugerre, and M. Legrand Benefit of treatment interruption in HIV-infected patients with multiple therapeutic failures: a randomized controlled trial (ANRS 097) AIDS 18 2004 217 226
17. R.Y. Chen, A.O. Westfall, J.L. Raper, G.A. Cloud, A.K. Chatham, and E.P. Acosta Immunologic and virologic consequences of temporary antiretroviral treatment interruption in clinical practice AIDS Res. Hum. Retroviruses 18 2002 909 916
18. G.M. Ortiz, M. Wellons, J. Brancato, H.T. Vo, R.L. Zinn, and D.E. Clarkson Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects Proc. Natl. Acad. Sci. USA 98 2001 13288 13293
19. E. Papasavvas, G.M. Ortiz, R. Gross, J. Sun, E.C. Moore, and J.J. Heymann Enhancement of human immunodeficiency virus type 1-specific CD4 and CD8 T cell responses in chronically infected persons after temporary treatment interruption J. Infect. Dis. 182 2000 766 775
20. A.U. Neumann, R. Tubiana, V. Calvez, C. Robert, T.S. Li, and H. Agut HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. Comet Study Group AIDS 13 1999 677 683
21. L. Ruiz, J. Martinez-Picado, J. Romeu, R. Paredes, M.K. Zayat, and S. Marfil Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression AIDS 14 2000 397 403
22. H. Hatano, S. Vogel, C. Yoder, J.A. Metcalf, R. Dewar, and R.T. Davey Jr. Pre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression AIDS 14 2000 1357 1363
23. P.M. Tarwater, M. Parish, and J.E. Gallant Prolonged treatment interruption after immunologic response to highly active antiretroviral therapy Clin. Infect. Dis. 37 2003 1541 1548
24. J.M. Kilby, P.A. Goepfert, A.P. Miller, J.W. Gnann Jr., M. Sillers, and M.S. Saag Recurrence of the acute HIV syndrome after interruption of antiretroviral therapy in a patient with chronic HIV infection: A case report Ann. Intern. Med. 133 2000 435 438
25. A. Oxenius, D.A. Price, H.F. Gunthard, S.J. Dawson, C. Fagard, and L. Perrin Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection Proc. Natl. Acad. Sci. USA 99 2002 13747 13752
26. F. Garcia, M. Plana, G. Mestre, M. Arnedo, C. Gil, and J.M. Miro Immunological and virological factors at baseline may predict response to structured therapy interruption in early stage chronic HIV-1 infection AIDS 16 2002 1761 1765
27. S.G. Deeks, C.M. Kitchen, L. Liu, H. Guo, R. Gascon, and A.B. Narvaez Immune activation set-point during early HIV infection predicts subsequent CD4+ T cell changes independent of viral load Blood 2004 [Epub ahead of print]